ZURICH, Switzerland, June 25, 2007 (PRIME NEWSWIRE) -- As announced today, the Swedish Medical Product Agency (MPA) has accepted Nobel Biocare’s action plan with some additional clarifications. Nobel Biocare welcomes the renewed confirmation of market clearance without constraints by the MPA for NobelDirect(tm) and NobelPerfect(tm) one-piece implants.
